It was demonstrated that epigallocatechin-gallate is able to regulate the progression of hepatocellular carcinoma by modulating key molecular targets such as NFκB and p53; ERK1/2 and PI3K–Akt–mTOR; and FGF and VEGF. This evidence concerns the gene TP53 and hepatocellular carcinoma.